137 related articles for article (PubMed ID: 27239961)
1. An ANCCA/PRO2000-miR-520a-E2F2 regulatory loop as a driving force for the development of hepatocellular carcinoma.
Huang J; Yang J; Lei Y; Gao H; Wei T; Luo L; Zhang F; Chen H; Zeng Q; Guo L
Oncogenesis; 2016 May; 5(5):e229. PubMed ID: 27239961
[TBL] [Abstract][Full Text] [Related]
2. Significance of PRO2000/ANCCA expression, a novel proliferation-associated protein in hepatocellular carcinoma.
Yang J; Huang J; Luo L; Chen Z; Guo Y; Guo L
Cancer Cell Int; 2014; 14():33. PubMed ID: 24708861
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-218 and microRNA-520a inhibit cell proliferation by downregulating E2F2 in hepatocellular carcinoma.
Dong Y; Zou J; Su S; Huang H; Deng Y; Wang B; Li W
Mol Med Rep; 2015 Jul; 12(1):1016-22. PubMed ID: 25816091
[TBL] [Abstract][Full Text] [Related]
4. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
Wang P; Chen S; Fang H; Wu X; Chen D; Peng L; Gao Z; Xie C
Oncotarget; 2016 Jan; 7(1):929-45. PubMed ID: 26498144
[TBL] [Abstract][Full Text] [Related]
5. MiR-490-5p inhibits the metastasis of hepatocellular carcinoma by down-regulating E2F2 and ECT2.
Fang ZQ; Li MC; Zhang YQ; Liu XG
J Cell Biochem; 2018 Nov; 119(10):8317-8324. PubMed ID: 29932246
[TBL] [Abstract][Full Text] [Related]
6. Expression and Prognostic Role of E2F2 in Hepatocellular Carcinoma.
Shen S; Wang Y
Int J Gen Med; 2021; 14():8463-8472. PubMed ID: 34824545
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells.
Ma Y; Deng F; Li P; Chen G; Tao Y; Wang H
Biomed Pharmacother; 2018 May; 101():648-655. PubMed ID: 29518611
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
10. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
Wang K; Liang Q; Wei L; Zhang W; Zhu P
Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
[TBL] [Abstract][Full Text] [Related]
13. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
14. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-197-3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma.
Ni JS; Zheng H; Huang ZP; Hong YG; Ou YL; Tao YP; Wang MC; Wang ZG; Yang Y; Zhou WP
Oncol Lett; 2019 Feb; 17(2):2317-2327. PubMed ID: 30675297
[TBL] [Abstract][Full Text] [Related]
16. miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma.
Chang RM; Xiao S; Lei X; Yang H; Fang F; Yang LY
Clin Cancer Res; 2017 May; 23(10):2593-2604. PubMed ID: 27827315
[No Abstract] [Full Text] [Related]
17. Suppressive role of microRNA-29 in hepatocellular carcinoma via targeting IGF2BP1.
Yang J; Gong X; Yang J; Ouyang L; Xiao R; You X; Ouyang Y
Int J Clin Exp Pathol; 2018; 11(3):1175-1185. PubMed ID: 31938212
[TBL] [Abstract][Full Text] [Related]
18. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
[TBL] [Abstract][Full Text] [Related]
20. lncRNA NORAD promotes hepatocellular carcinoma progression via regulating miR-144-3p/SEPT2.
Tian Q; Yan X; Yang L; Liu Z; Yuan Z; Shen Z; Zhang Y
Am J Transl Res; 2020; 12(5):2257-2266. PubMed ID: 32509217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
